Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-interventional Observational Study to Evaluate the Efficacy and Safety of Non-immune Staphylokinase in Reperfusion Therapy of Ischemic Stroke in Routine Clinical Practice

NCT05697575 is registered in ClinicalTrials.gov with National Society for Neurosonology and Cerebral Circulation as lead sponsor.

NCT NCT05697575
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05697575 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-interventional Observational Study to Evaluate the Efficacy and Safety of Non-immune Staphylokinase in Reperfusion Therapy of Ischemic Stroke in Routine Clinical Practice
Lead sponsor
National Society for Neurosonology and Cerebral Circulation
Phase
Observational
Overall status
Recruiting
Start date
February 1, 2023
Completion date
May 10, 2030
Enrollment
336 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute stroke